Trend analysis and regional tumor incidence in Germany for testicular cancer between 2003 and 2014.

M. P. Brandt , K. M. Gust , D. Bon , I. Tsaur
Journal of Andrology 7 ( 4) 408 -414

6
2019
From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy.

R. Mager , M. P. Brandt , H. Borgmann , K. M. Gust
International Urology and Nephrology 49 ( 9) 1537 -1544

10
2017
Rare Case of Excessive Beta-Human Chorionic Gonadotropin Producing Intrascrotal Leiomyosarcoma: Diagnostic Pitfalls and Therapeutic Implications

Maximilian Peter Brandt , Thomas Hoefner , Kilian Martin Gust , Marit Ahrens
Clinical Genitourinary Cancer 14 ( 4) e409 -e412

1
2016
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy

Marco Moschini , Francesco Soria , Tobias Klatte , Gregory J. Wirth
Clinical Genitourinary Cancer 15 ( 2) e267 -e273

20
2017
Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.

Marco Moschini , Francesco Soria , Martin Susani , Stephan Korn
Bladder Cancer (Amsterdam, Netherlands) 3 ( 3) 161 -169

6
2017
Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study.

R Mathieu , M Moschini , B Beyer , K M Gust
Prostate Cancer and Prostatic Diseases 20 ( 2) 197 -202

21
2017
Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature

Andrea Mari , Mohammad Abufaraj , Killian M Gust , Shahrokh F Shariat
Current Opinion in Urology 28 ( 2) 214 -218

23
2018
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

Daniel Lee , Malte Rieken , Sharokh Shariat , Evanguelos Xylinas
Journal of Urology 198 ( 6) 1269 -1277

4
2017
Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis.

Melanie R. Hassler , Mohammad Abufaraj , Shoji Kimura , Judith Stangl-Kremser
Clinical Genitourinary Cancer 18 ( 2)

11
2020
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non–muscle-invasive Bladder Cancer

David D'Andrea , Marco Moschini , Kilian Gust , Mohammad Abufaraj
Clinical Genitourinary Cancer 15 ( 5) 755 -764

21
2017
MP49-09 ACTIVATION OF IFN/STAT1 SIGNALING IN CISPLATIN/GEMCITABINE RESISTANT BLADDER CANCER

Tetsutaro Hayashi , Roland Seiler , Robert H. Bell , Susan Ettinger
The Journal of Urology 193 ( 4)

2015
MP8-11 QUALITY, ACCESSIBILITY AND READABILITY OF ONLINE HEALTH INFORMATION ON URINARY INCONTINENCE

Hendrik Borgmann , Jan-Henning Wölm , Michael Reiter , Kilian Gust
The Journal of Urology 193 ( 4)

2015
Strategy of robotic surgeons to exert public influence through Twitter

Hendrik Borgmann , Jan Woelm , Karen Nelson , Kilian Gust
The International Journal of Medical Robotics and Computer Assisted Surgery 13 ( 1) e1739

2
2017
Phonological deficit in school children is reflected in the Mismatch Negativity

Ulrich Bitz , Kilian Gust , Manfred Spitzer , Markus Kiefer
Neuroreport 18 ( 9) 911 -915

15
2007
PD13-08 STRATIFICATION OF INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: IMPLICATIONS FOR ADJUVANT THERAPIES.

Francesco Soria* , David D'Andrea , Kilian Gust , Paolo Gontero
The Journal of Urology 201

2019
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.

Mehmet Özsoy , Marco Moschini , Harun Fajkovic , Francesco Soria
Prostate Cancer and Prostatic Diseases 21 ( 1) 100 -105

6
2018
Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors.

Lukas Jennewein , Georg Bartsch , Kilian Gust , Hans‑Michael Kvasnicka
Oncology Letters 15 ( 6) 9852 -9860

14
2018
The role of taxane-based chemotherapy in the treatment of prostate cancer.

Nicolai A. Huebner , Shahrokh F. Shariat , Irene Resch , Kilian Gust
Current Opinion in Urology 30 ( 4) 527 -533

2
2020